Skip to content. | Skip to navigation

Garvan Institute

Sections
 

Professor Edward Kraegen

 

Senior Principal Research Fellow; Group Leader, Diabetes and Obesity Research Program, Garvan Institute of Medical Research; NHMRC Senior Principal Research Fellow; Professor, Faculties of Medicine and Medical Sciences, The University of New South Wales

Email: e.kraegen 'at' garvan.org.au
Research Group: Kraegen

 
 

Education

1970 PhD, The University of New South Wales
1965 BSc (Hons), The University of New South Wales

Publications

Cleasby ME, Davey JR, Reinten TA, Graham MW, James DE, Kraegen EW, Cooney GJ. Acute bidirectional manipulation of muscle glucose uptake by in vivo electro-transfer of constructs targeting glucose transporter genes. Diabetes 2005; 54(9):2702-11.

Cleasby ME, Dzamko N, Hegarty BD, Cooney GJ, Kraegen EW, Ye JM. Metformin prevents the development of acute lipid-induced insulin resistance in the rat through altered hepatic signaling mechanisms. Diabetes 2004; 53(12):3258-66.

Iglesias MA, Ye J-M, Frangioudakis G, Saha AK, Tomas E, Ruderman NB, Cooney GJ, Kraegen EW. AICAR administration causes an apparent enhancement of muscle and live insulin action in insulin resistant high-fat fed rats. Diabetes 2002; 51:2886-2894.

Yu C, Chen Y, Cline GW, Zhang D, Zong H, Wang Y, Bergeron R, Kim JK, Cushman SW, Cooney GJ, Atcheson B, White MF, Kraegen EW, Schulman GI. Mechanism by which fatty acids inhibit insulin activation of IRS-1 associated phosphatdylinositol 3-kinase activity in muscle. J Biol Chem 2002; 277:50230-50236.

Cooney GJ, Thompson AL, Furler SM, Ye J, Kraegen EW. Muscle long-chain Acyl CoA esters and insulin resistance. Ann NY Acad Sci 2002; 967:196-207.

Ye J-M, Doyle PJ, Iglesias MA, Watson DG, Cooney GC, Kraegen EW. Peroxisome proliferator-activated receptor (PPAR)-α activation lowers muscle lipids and improves insulin sensitivity in high fat-fed rats: comparison with PPAR−γ activation. Diabetes 2001; 50:411-417.

Oakes ND, Kennedy CJ, Jenkins AB, Laybutt DR, Chisholm DJ, Kraegen EW. A new antidiabetic agent, BRL 49653, reduces lipid availability and improves insulin action and glucoregulation in the rat. Diabetes 1994; 43:1203-1210.

Jenkins AB, Storlien LH, Chisholm DJ, Kraegen EW. Effects of nonesterified fatty acid availability on tissue-specific glucose utilisation in rats in vivo. J Clin Invest 1988; 82:293-299.

Storlien LH, Kraegen EW, Chisholm DJ, Ford GL, Bruce DG, Pascoe WS. Fish oil prevents insulin resistance induced by high-fat feeding in rats. Science 1987; 237:885-888.

Kraegen EW, James DE, Bennett SP, Chisholm DJ. In vivo insulin sensitivity in the rat determined by euglycemic clamp. Am J Physiol 1983; 245 E1-E7


Search for all publications by Edward Kraegen

 
 
 

Areas of Interest

type 2 diabetes, nsulin resistance, insulin action,insulin resistance, pharmacology, fatty acids, AMP protein kinases, muscle metabolism
 

News

 

Traditional Chinese Medicine for diabetes has scientific backing

01 Aug 2006
Reports of a traditional Chinese medicine having beneficial effects for people suffering from type 2 diabetes now has some scientific evidence to back up the claims.
 
 

Personal tools